4.64% -0.21

Atea Pharmaceuticals Inc (AVIR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	26.89% 35.10	48.01	54.93	45.57	41.34
Depreciation and Amortization	0.00% 0.104	0.104	0.104	0.104	0.104
Operating Income/Loss	26.89% -35.10	-48.01	-54.93	-45.57	-41.34
Income/Loss From Continuing Operations Before Tax	27.50% -32.91	-45.39	-51.63	-41.85	-36.95
Income Tax Expense/Benefit	52.00% 0.024	0.05	-6.768	0.196	0.207
Net Income/Loss	27.52% -32.93	-45.44	-44.87	-42.05	-37.16
Basic Average Shares	1.08% 80.05	79.20	-1.1285	79.05	83.75
Diluted Average Shares	1.08% 80.05	79.20	-1.1285	79.05	83.75
Basic Earnings Per Share	28.07% -0.41	-0.57	-0.57	-0.53	-0.44
Diluted Earnings Per Share	28.07% -0.41	-0.57	-0.57	-0.53	-0.44

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%